Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2022-06-07 00:00:00 ET · period of report 2022-06-03 · accession 0001567619-22-012432 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-07 | 2022-06-03 | BMRN | Ajer Jeffrey Robert | EVP, Chief Commercial Off | F - Tax | $77.49 | -7,021 | 47.1K | -13% | -$544.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-03 | F | D | 7,021 | $77.49 | 47,088 | D | — | — |